Antiproliferative activity from Aldama arenaria (Baker) E. E. Schill. & Panero

Chloroform extract (CE) and fractions obtained from Aldama arenaria roots were evaluated for their in vitro antiproliferative activity against 10 human tumor cell lines [leukemia (K-562), breast (MCF-7), ovary expressing a multidrug-resistant phenotype (NCI/ADR-RES), melanoma (UACC-62), lung (NCI-H4...

Full description

Saved in:

Bibliographic Details
Published in:	Boletín latinoamericano y del Caribe de plantas medicinales y aromáticas Vol. 20; no. 1; pp. 51 - 60
Main Authors:	de Oliveira, Adriana da S. S., Imamura, Paulo M., Ruiz, Ana L. T. G., Appezzato-da-Glória, Beatriz, de Oliveira, Tuane, Garcia, Vera L.
Format:	Journal Article
Language:	English
Published:	01-01-2021
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Chloroform extract (CE) and fractions obtained from Aldama arenaria roots were evaluated for their in vitro antiproliferative activity against 10 human tumor cell lines [leukemia (K-562), breast (MCF-7), ovary expressing a multidrug-resistant phenotype (NCI/ADR-RES), melanoma (UACC-62), lung (NCI-H460), prostate (PC-3), colon (HT29), ovary (OVCAR-3), glioma (U251), and kidney (786-0)]. CE presented weak to moderate antiproliferative activity (mean log GI50 1.07), whereas fractions 3 and 4, enriched with pimarane-type diterpenes [ent-pimara-8(14),15-dien-19-oic acid and ent-8(14),15-pimaradien-3β-ol], presented moderate to potent activity for most cell lines, with mean log GI50 of 0.62 and 0.59, respectively. The results showed promising in vitro antiproliferative action of the samples obtained from A. arenaria, with the best results for NCI/ADR-RES, HT29, and OVCAR-3, and TGI values ranging from 5.95 to 28.71 µg.mL-1, demonstrating that compounds of this class may be potential prototypes for the discovery of new therapeutic agents.
ISSN:	0717-7917 0717-7917
DOI:	10.37360/blacpma.21.20.1.4